Acute respiratory and airways conditions have made it onto the Cochrane priority list of topics to review 13 times.
Published for the first time, Cochrane says the list sets out topics that ‘best meet the needs of healthcare and health policy decision makers.’
They hope publicising the list will act as a stimulus to encourage funders to support production of the reviews, and also attract experienced and skilled research teams to take on the vacant titles on the list.
Top Cochrane list of priority areas for review
- Interventions for reducing antibiotic resistance (New)
- Interventions for reducing unecessary antibiotic prescribing (New)
- Antibiotics for acute otitis media in children (Update)
- Azithromycin for acute lower respiratory tract infection (Update)
- Delayed antibiotics for respiratory infection (Update)
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infection (Update)
- Shared decision making for acute respiratory infections in primary care (New)
- Xylitol for preventing acute otitis media in children up to 12 years of age (Update)
- Long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease (New)
- Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease (New)
- High dose versus low dose oral steroids for asthma attack (New)
- Exhaled nitric oxide levels to guide treatment for children with asthma (New)
- Exhaled nitric oxide levels to guide treatment for adults with asthma (New)